The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial.

CONCLUSIONS: These results show that young women diagnosed with breast cancer experienced only a short-term decrease in QoL from the addition of goserelin, in order to preserve ovarian function during chemotherapy treatment.
PMID: 32505861 [PubMed - as supplied by publisher]

Source: Breast - May 28, 2020 Category: Cancer & Oncology Authors: R L, A Y, J M, L F, V J Tags: Breast Source Type: research